Volume : 09, Issue : 08, August – 2022

Title:

34.FORMULATION, DEVELOPMENT AND EVALUATION OF TRANSDERMAL DRUG DELIVERY SYSTEM OF CIPROFLOXACIN

Authors :

Mausam Kumar Sahu*, Rupesh Kumar Jain, Pushpendra Kumar Khangar, Vivek Jain

Abstract :

In transdermal drug delivery system (TDDS) the drug is mainly delivered through the skin with the aid of transdermal patch which is a medicament adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and to the blood stream. Now a day TDD is a well-accepted means of delivering many drugs to the systemic circulation in order to achieve a desired pharmacological outcome. The current research is to develop ciprofloxacin transdermal patches which may improves drug dissolution, fast absorption, improves the solubilization of lipophilic drugs, prolonged release and enables reduction in dose. The results of the physicochemical characterization of the patches are shown in Table. The thickness ranged between 154 and 179 µm, which showed their uniformity in thickness. Slight changes in weights among the patches was observed with all formulations and ranged from 11.85 mg and 10.34 mg. Drug content ranged from 96.5% to 98.9 %, which indicates good uniformity among all formulations. This result indicates that the process employed to prepare patches in this study was capable of producing patches with uniform drug content and minimal patch variability.
Key words: Ciprofloxacin, Transdermal Patches, Formulation, Evaluation

Cite This Article:

Please cite this article in press Mausam Kumar Sahu et al, Formulation, Development and Evaluation of Transdermal Drug Delivery System of Ciprofloxacin.,Indo Am. J. P. Sci, 2022; 09(8).

,

Number of Downloads : 10

References:

1. Bamisaye A, Eromosele CO, Dare EO, Akinloye OA, Manickam S, Idowu MA. Development and characterization of PEGylated ofloxacin and ciprofloxacin loaded sandbox oil based nanoemulsion and its potential for transdermal drug delivery. Journal of Chemical Society of Nigeria. 2020 Mar 30;45(2).
2. Ahmed A, Karki N, Charde R, Charde M, Ganghare B. Transdermal Drug Delivery System an Overview. Int J Biomed Adv Res. 2011; 2: 38-56.
3. Shaik HR,BabuRH, Mohiddin MK, Vineela J, Raviteja A, Pathuri RK, Gajavalli SR, Naidu LV. Transdermal Drug Delivery System – Simplified Medication Regimen – A Review. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 2011,2(4),223-238.
4. Gupta V, Yadav SK, Dwivedi AK, Gupta N. Transdermal Drug Delivery: Post, Present, Future Trends. Int J Pharm Life Sci. 2011; 12: 1096-1106.
5. Ravi S, Sharma PK, Bansal M. A Review: Transdermal Drug Delivery Of Nicotine. Int J Drug Dev Res. 2011; 3: 01-08.
6. Patel D, Patel N, Parmar M, Kaur N. Transdermal Drug Delivery System: Review. Int J Bio Pharm Toxicol Res. 2011; 1: 61-80.
7. Hafeez A, Jain U, Singh J, Maurya A, Rana L. Recent Advances in Transdermal Drug Delivery System (TDDS): An Overview. J Sci Innov Res. 2013; 2: 733- 744.
8. Sandhu P, Bilandi A, Kataria S, Middha A. Transdermal Drug Delivery System (Patches) Application in Present Scenario. Int J Res Pharm Chem. 2011; 1: 1139-1151.
9. Sharma N, Parashar B, Sharma S, Mahajan U. Blooming Pharma Industry with Transdermal Drug Delivery System. Indo Global J Pharm Sci. 2010; 2: 262-278.
10. Sachan NK, Pushkar S, Bhattacharya A. Transdermal Approaches In Drug Delivery. Scholar Res. Lib J. 2009; 1: 34-47.
11. Mohd Nauman Saleem and Mohammad Idris. Formulation Design and Development of a Unani Transdermal Patch for Antiemetic Therapy and Its Pharmaceutical Evaluation. Scientifica 2016, Article ID 7602347.